Ertugliflozin to Reduce Arrhythmic Burden in ICD/CRT patientS (ERASe-Trial) - a Phase III Study (ERASE)
Ertugliflozin to Reduce Arrhythmic Burden in Implantable Cardioverter-defibrillators (ICD)/Cardiac Resynchronisation Therapy(CRT) patientS (ERASe-Trial) - a Phase III Study
Sponsor: Elisabethinen Hospital
Terminated
The feasibility (recruitment) of the high number of patients (402 patients with HFrEF or HFmrEF) was impossible due to the rapid increase in SGLT2 inhibitors in patients with heart failure.
Other terminated trials from Elisabethinen Hospital
Other Cardiac Resynchronization Therapy trials with similar outcome
A PHASE3 clinical study on Cardiac Resynchronization Therapy and Heart Failure With Mid Range Ejection Fraction, this trial is terminated or withdrawn. The trial is conducted by Elisabethinen Hospital and has accumulated 14 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
14 versions recorded-
Jun 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Jun 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Nov 2023 — Jul 2024 [monthly]
Terminated PHASE3
Status: Active Not Recruiting → Terminated
-
Aug 2023 — Nov 2023 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
▶ Show 9 earlier versions
-
May 2022 — Aug 2023 [monthly]
Recruiting PHASE3
-
Feb 2022 — May 2022 [monthly]
Recruiting PHASE3
-
Oct 2021 — Feb 2022 [monthly]
Recruiting PHASE3
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2021 — May 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
-
Nov 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Elisabethinen Hospital
- General Hospital Linz
- Klinik Ottakring
- Klinikum Klagenfurt am Wörthersee
- Landesklinkum Wiener Neustadt
- Medical University Innsbruck
- Medical University of Graz
- Medical University of Vienna
For direct contact, visit the study record on ClinicalTrials.gov .